Page last updated: 2024-09-02

st 1435 and ethinyl estradiol-norgestrel combination

st 1435 has been researched along with ethinyl estradiol-norgestrel combination in 2 studies

Compound Research Comparison

Studies (st 1435)	Trials (st 1435)	Recent Studies (post-2010) (st 1435)	Studies (ethinyl estradiol-norgestrel combination)	Trials (ethinyl estradiol-norgestrel combination)	Recent Studies (post-2010) (ethinyl estradiol-norgestrel combination)
97	31	33	482	145	94

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burggraaf, J; de Kam, ML; Kluft, C; Meijer, P; Ménard, J; Rad, M; Sitruk-Ware, RL; Sivin, I	1
Burggraaf, J; Cohen, AF; de Kam, ML; Kluft, C; Rad, M	1

Trials

1 trial(s) available for st 1435 and ethinyl estradiol-norgestrel combination

Article	Year
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables. American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:1 Topics: Activated Protein C Resistance; Adolescent; Adult; Blood Coagulation Factors; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Humans; Immunoradiometric Assay; Norprogesterones; Plasminogen; Protein C; Sex Hormone-Binding Globulin	2006

Article

Year

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.

American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:1

Topics: Activated Protein C Resistance; Adolescent; Adult; Blood Coagulation Factors; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Humans; Immunoradiometric Assay; Norprogesterones; Plasminogen; Protein C; Sex Hormone-Binding Globulin

2006

Other Studies

1 other study(ies) available for st 1435 and ethinyl estradiol-norgestrel combination

Article	Year
Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE. Contraception, 2012, Volume: 86, Issue:3 Topics: Angiotensinogen; Blood Coagulation Factors; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Discriminant Analysis; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norprogesterones; Risk; Sex Hormone-Binding Globulin; Thrombosis; Triglycerides	2012

Article

Year

Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.

Contraception, 2012, Volume: 86, Issue:3

Topics: Angiotensinogen; Blood Coagulation Factors; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Discriminant Analysis; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norprogesterones; Risk; Sex Hormone-Binding Globulin; Thrombosis; Triglycerides

2012